KKR launches Allyntra, a precision-engineered medtech platform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Nasdaq lags on angst over AI spending ahead of earnings reports
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil falls on report China pushing for end US-Iran war
- Why Meta, Microsoft, and Nvidia are championing open-weight AI
- FDA approves Tylenol with Naproxen as first OTC combo pain reliever
- AMD (AMD) PT Raised to $1,250 at Baird
- Pakistan, Iran explore path towards new talks with US in a China-initiated push, sources say
- Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
- Nasdaq lags on angst over AI spending ahead of earnings reports
KKR Launches Allyntra, an Engineered Solutions Platform for Medical Technology and Precision Industries
July 9, 2026 6:59 AM EDTRobbie Atkinson appointed as CEO and Brian Highley appointed as Chairman
NEW YORK--(BUSINESS WIRE)-- KKR today announced the launch of Allyntra (Allyntra or the Company), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKRs existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntras growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial... More
